Upgrade to SI Premium - Free Trial

Marvell (MRVL) PT Raised to $195 at UBS

May 4, 2026 9:32 AM
UBS analyst Timothy Arcuri raised the price target on Marvell (NASDAQ: MRVL) to $195.00 (from $120.00) while maintaining a Buy rating.

Categories

Analyst PT Change